January 31, 2017
Terumo Opens a Branch in Yangon
Aiming to Contribute to the Development of Medical Technologies in Myanmar
TOKYO, JAPAN – Jan. 31, 2017 – Terumo Corporation (TSE: 4543) announced today that its Yangon Branch opened for business in January 2017.
In Myanmar, economic growth has been strong1 and healthcare market has been expanding since the country’s transition from military rule to a civilian government in 2011. Growth is projected to continue in the future, but maintenance of healthcare systems and facilities has been falling behind.2
Terumo began doing business in Myanmar in the 1990s,3 and has continuously engaged in commercial activities in the country since that time. As a result, Terumo now has substantial market shares in Myanmar for a wide range of products, including interventional systems, oxygenators, blood bags, blood glucose monitors, and infusion systems. By opening a branch in Yangon, the country’s largest city, Terumo intends to establish more locally based operations and expand its business while also aiming to contribute to the development of medical technologies in the country by offering healthcare training and other initiatives.
Overview of the Yangon Branch
|Name:||Terumo Singapore Pte. Ltd. (Yangon Branch)|
|Date of establishment:||June 23, 2016|
|Date of opening:||January 9, 2017|
|Number of employees:||3 (As of January, 2017)|
1. Real GDP is forecast to grow between 6 – 9% annually according to the International Monetary Fund’s World Economic Outlook Database
2. According to a report on global healthcare conditions published by Japan’s Ministry of Foreign Affairs
3. Sales are mainly carried out through local sales agents
About Terumo Corporation
Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.